The heart was exposed by midsternal thoracotomy. The left anterior descending coronary artery by guest on
pigs; and tiapamil, 9 mg/kg, 10 pigs. Drugs were administered intravenously in two equally divided doses during a 5-minute period starting 30 minutes before and 10 minutes after CAL.
Statistical Methods
All values are expressed as mean + SEM. The X and Fisher's exact tests with Bonferroni's correction were used to evaluate the incidence of VF.
Student's t test, allowing for unequal variances, and one-way analysis of variance were applied. When comparing the duration of VT where the sample variance lacked homogeneity, logarithmic transformations were used. Values of p<0.05 were considered significant.
Results

Size of Ischemic Zone
Sixty-six pigs were used in this study. Results from three pigs were not processed. Two of these (one control and one verapamil 0.2 mg/kg) had ischemic zones that were greater than 22%, and one pig (verapamil 0.6 mg/kg) had an ischemic zone that was less than 5% of total LV mass. Other results are summarized in Table 1 .
Incidence of Ventricular Arrhythmias
In controls, phase lB ventricualr arrythmias'9 occurred 15-30 minutes after CAL. The majority of episodes of VF and runs of VT and a high incidence of ventricular premature systoles were confined to this period. Only isolated ventricular premature systoles and brief runs of VT occasionally occurred before 15 minutes and between 30 and 90 minutes after CAL.
VF occurred in 22 of 25 controls at 20.8 ± 3.7 minutes after CAL. In five of the 22 pigs, VF could not be terminated within 90 seconds; therefore, the experiments were terminated. Verapamil 0.2 mg/kg did not decrease the incidence of VF. Verapamil 0.6 mg/kg, as well as tiapamil 6 mg/kg, decreased the incidence of VF. Five of 10 pigs in the group that received tiapamil 9 mg/kg had VF (p=0.06 vs. controls with Bonferroni's correction). Verapamil (Figure 1 ).
Blood flow was not studied in the groups that received verapamil 0.2 mg/kg and tiapamil 9 mg/kg. Discussion There is considerable evidence that calcium channel antagonists can prevent ventricular tachyarrythmias during the early phase of acute myocardial infarction in animal models.2,7,20,21 The antiarrhythmic dose of verapamil in our model was 0.6 mg/kg, which is similar to that reported in other in vivo studies.7-9 Verapamil at this supraclinical dose caused a severe suppression of mechanical function as evident by a fall of about 50% in LV dP/dtmax. In a dog model of regional ischemia, superimposed on previous infarction, verapamil 0.4 mg/kg was used to suppress ventricular arrhythmias, but LV mechanical function was not monitored.9 Tiapamil up to 3 mg/kg produced no adverse effects and even improved hemodynamic status in dogs without CAL,11 whereas tiapamil 1-2 mg/kg did not impair LV mechanical function in dogs22 and baboons23 with developing infarction. We therefore selected a dose of tiapamil higher than those previously used to ensure that any impairment of LV function would become apparent. Tiapamil has approximately one tenth the negative inotropic potency of verapamil in isolated preparations.1' Having established that the antiarrhythmic dose of verapamil in our model was 0.6 mg/kg, we therefore examined the influence of a 10-fold higher dose of tiapamil. Tiapamil 6 mg/kg decreased both the incidence of VF and the duration of VT, and in addition, it maintained predrug and preligation LV mechanical function for the duration of the experiments. An increase in the dose of tiapamil to 9 mg/kg was associated with a decrease in antiarrhythmic activity, a phenomenon previously ascribed to calcium channel antagonists.24 Therefore, the major difference between verapamil and tiapamil is that tiapamil maintained LV mechanical function at a dose exhibiting ventricular antiarrhythmic activity. The dose of tiapamil associated with ventricular antiarrhythmic activity in our study was approximately threefold higher than the dose (2 mg/kg) that prevented supraventricular tachycardia25 or that maintained mechanical function during early myocardial infarction in patients.'0 In another study with patients, tiapamil 13 mg/kg given as an infusion during a 4-hour period reduced ventricular ectopic beats. 26 LV dP/dtmax was used as an index of LV mechanical function in our study. In patients, this index is useful in assessing acute changes in the inotropic state.27 In open-chest animals, both preload and afterload can influence LV dP/dtmax with increases in both variables increasing LV dP/dtmax.28 In our experiments, the higher doses of verapamil caused LVEDP to rise, which could have increased LV dP/dtmax, whereas the fall in both blood pressure and heart rate could have caused LV dP/dtmax to fall. However, Figure 1 of Wallace et a128 shows that relatively small changes in mean arterial pressure and heart rate as found in our study are unlikely to have had a major influence on LV dP/dtmax. Further- whereas a dose of verapamil (0.6 mg/kg) that likewise decreased VF did so at the expense of a major suppression of the LV mechanical function. Although the prevention of VF by tiapamil was not as marked as that by verapamil, the hemodynamic deterioration by verapamil suggests that there would be a high risk-to-benefit ratio. LV dP/dtmax was used as an index of global ventricular function in this study. Tiapamil induced increases in sympathetic activation of nonischemic zones, and its effects on global contractility could have affected the measurements. It should be noted that we did not measure cardiac output or systemic vascular resistance. As tiapamil has a proven effect in reducing systemic vascular resistance and in increasing cardiac output in patients with acute myocardial infarction,10 it is possible that similar effects could have occurred in our model because of the absence of changes in LV dP/dt and of the fall in arterial pressure.
The antiarrhythmic activities of verapamil and tiapamil appear to be multifactorial. Tiapamil markedly increased blood flow in the nonischemic zone, which probably reflects its property of selective coronary artery vasodilation.12 We could demonstrate the existence of a narrow "border zone" of blood flow in pigs.29 The small increase in blood flow in the peripheral ischemic zone in this study may reflect an increase in collateral flow by tiapamil or a mixture of blood flow rates in ischemic and nonischemic invaginations in this zone. In either situation, an increase in tissue viability in the peripheral ischemic zone is a possibility. A narrow electrophysiological "border zone" exists in the pig heart.30 Janse and Kleber3' have proposed that the initiating beat of VT and VF in the isolated, bloodperfused pig heart originates in the nonischemic region of the "border zone." In our study, the improvement in blood flow in the "border zone" could therefore have decreased arrhythmia development. However, the antiarrhythmic activity of verapamil in our study was not associated with an improved myocardial blood flow. A similar dissociation was described by Sherman and coworkers. 
